Pancreatic Cancer Research

ResearcherUniversity of PisaActive in the last 2 years

Giulia Peduzzi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0009-4313-474X; OpenAlex author ID A5016817014. Sources: OpenAlex.

Their work

Papers
17 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
63
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 3 papers · 2025: 10 papers

Papers 17

  1. Polymorphisms within autophagy-related genes as susceptibility biomarkers for pancreatic cancer: A meta-analysis of three large European cohorts and functional… First author DOI 10.1002/ijc.35196↗
  2. Evaluating Sex Disparity in Pancreatic Ductal Adenocarcinoma Risk in the UK Biobank Cohort. Co-author DOI 10.1002/ueg2.70102↗
  3. Explainable machine learning identifies a polygenic risk score as a key predictor of pancreatic cancer risk in the UK Biobank. Co-author DOI 10.1016/j.dld.2024.11.010↗
  4. Author's Reply: Comment on "Analysis of exposome and genetic variability suggests stress as a major contributor for development of pancreatic ductal adenocarci… Co-author DOI 10.1016/j.dld.2024.12.025↗
  5. Biomarkers, omics and artificial intelligence for early detection of pancreatic cancer. Co-author DOI 10.1016/j.semcancer.2025.02.009↗
  6. From classical approaches to artificial intelligence, old and new tools for PDAC risk stratification and prediction. Co-author DOI 10.1016/j.semcancer.2025.03.004↗
  7. The exposome and pancreatic cancer, lifestyle and environmental risk factors for PDAC. Co-author DOI 10.1016/j.semcancer.2025.05.004↗
  8. Long or short? Telomere length and pancreatic cancer and its precursor lesions, a narrative review. Co-author DOI 10.1093/mutage/gead034↗
  9. A pleiotropy scan to discover new susceptibility loci for pancreatic ductal adenocarcinoma. Co-author DOI 10.1093/mutage/geae012↗
  10. Sex Disparities and Female Reproductive and Hormonal Factors Associated with Risk of Pancreatic Cancer in the European Prospective Investigation into Cancer an… Co-author DOI 10.3390/cancers17142275↗
  11. Potential association between PSCA rs2976395 functional variant and pancreatic cancer risk. Co-author DOI 10.1002/ijc.35046↗
  12. Analysis of exposome and genetic variability suggests stress as a major contributor for development of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.dld.2023.10.015↗
  13. Physical Activity, Sedentary Behavior, and Pancreatic Cancer Risk: A Mendelian Randomization Study. Co-author DOI 10.1210/jendso/bvae017↗
  14. The PANcreatic Disease ReseArch (PANDoRA) consortium: Ten years' experience of association studies to understand the genetic architecture of pancreatic cancer. Co-author DOI 10.1016/j.critrevonc.2023.104020↗
  15. Common variability in oestrogen-related genes and pancreatic ductal adenocarcinoma risk in women. Co-author DOI 10.1038/s41598-022-22973-9↗
  16. Genetic Polymorphisms Involved in Mitochondrial Metabolism and Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-21-0353↗
  17. Genetic polymorphisms in inflammatory genes and pancreatic cancer risk: a two-phase study on more than 14 000 individuals. First author DOI 10.1093/mutage/gez040↗

Closest collaborators

The 25 strongest of 63 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Daniele Campa · 12 shared papers, 2019–2025 · strength 2.57
  2. Manuel Gentiluomo · 9 shared papers, 2019–2025 · strength 1.72
  3. Riccardo Farinella · 6 shared papers, 2024–2025 · strength 1.36
  4. Federico Canzian · 7 shared papers, 2019–2025 · strength 1.32
  5. Cosmeri Rizzato · 4 shared papers, 2025 · strength 0.94
  6. Lívia Archibugi · 4 shared papers, 2022–2025 · strength 0.75
  7. Gabriele Capurso · 4 shared papers, 2022–2025 · strength 0.74
  8. Marco Calderisi · 2 shared papers, 2024–2025 · strength 0.42
  9. Eithne Costello · 2 shared papers, 2025 · strength 0.40
  10. Pinar Uysal Onganer · 2 shared papers, 2025 · strength 0.37
  11. Sabrina Gloria Giulia Testoni · 2 shared papers, 2022–2025 · strength 0.32
  12. Ľudmila Vodičková · 2 shared papers, 2022–2025 · strength 0.30
  13. Chiara Corradi · 1 shared paper, 2025 · strength 0.28
  14. Mateus Nóbrega Aoki · 2 shared papers, 2022–2025 · strength 0.27
  15. Verena Andrea Katzke · 2 shared papers, 2022–2025 · strength 0.26
  16. Roger Laughlin Milne · 1 shared paper, 2024 · strength 0.23
  17. Matteo Tacelli · 1 shared paper, 2025 · strength 0.22
  18. Ricardo Blázquez‐Encinas · 1 shared paper, 2025 · strength 0.22
  19. Neil Daniel · 1 shared paper, 2025 · strength 0.20
  20. Annalisa Comandatore · 1 shared paper, 2025 · strength 0.20
  21. Ruggero Ponz de Leon Pisani · 1 shared paper, 2025 · strength 0.20
  22. David J. Hughes · 1 shared paper, 2025 · strength 0.20
  23. Pavel Vodička · 1 shared paper, 2025 · strength 0.20
  24. Stefano Landi · 1 shared paper, 2025 · strength 0.20
  25. Juan Sáinz · 1 shared paper, 2025 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.